The talk will begin with a background of nucleic acid medicines in the clinic and how delivery challenges have played a role in the nature of clinical success to date. Then detail on emerging delivery strategy, central nervous system delivery, and non-viral nanomedicine delivery will be covered.
Samantha Sarett is a Director in the Genetic Medicine department at Eli Lilly. In her graduate research at Vanderbilt University, she designed effective and varied strategies for delivery of nucleic acid drugs. She built upon this foundation in postdoctoral work at AbbVie formulating diverse nanoparticle carriers before joining biotech Exicure. Since then, Dr Sarett has concentrated on design and evaluation of approaches to achieve central nervous system (CNS) delivery of nucleic acids. In her current research at Eli Lilly, she focuses on driving innovation and meaningful advances in the challenging and high-impact CNS delivery space.
This conference will be hosted by PI María José Alonso, Nanomedicine and Drug Delivery Group, CiMUS
Attendance certificates will be provided upon request to cimus.xestion [at] usc.es (cimus[dot]xestion[at]usc[dot]es). Please bear in mind to register by writing clearly the name and surname on the printed sheet. We will not be responsible for amending the records of anyone who fails to do so.